These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 16240274)

  • 41. Discriminating ability of Humphrey matrix perimetry in early glaucoma patients.
    Hong S; Chung W; Hong YJ; Seong GJ
    Ophthalmologica; 2007; 221(3):195-9. PubMed ID: 17440283
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Relationship between Humphrey 30-2 SITA Standard Test, Matrix 30-2 threshold test, and Heidelberg retina tomograph in ocular hypertensive and glaucoma patients.
    Bozkurt B; Yilmaz PT; Irkec M
    J Glaucoma; 2008; 17(3):203-10. PubMed ID: 18414106
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The prevalence of glaucomatous risk factors in patients from a managed care setting: a pilot evaluation.
    Fang EN; Law SK; Walt JG; Chiang TH; Williams EN
    Am J Manag Care; 2008 Feb; 14(1 Suppl):S28-36. PubMed ID: 18284313
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Nerve fiber layer thickness in glaucoma patients with asymmetric hemifield visual field loss.
    Badlani V; Shahidi M; Shakoor A; Edward DP; Zelkha R; Wilensky J
    J Glaucoma; 2006 Aug; 15(4):275-80. PubMed ID: 16865002
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Longitudinal changes in central corneal thickness and their relation to glaucoma status: an 8 year follow up study.
    Weizer JS; Stinnett SS; Herndon LW
    Br J Ophthalmol; 2006 Jun; 90(6):732-6. PubMed ID: 16481376
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Visual field changes after transient elevation of intraocular pressure in eyes with and without glaucoma.
    Chan KC; Poostchi A; Wong T; Insull EA; Sachdev N; Wells AP
    Ophthalmology; 2008 Apr; 115(4):667-72. PubMed ID: 17716733
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Risk factors for glaucoma onset and progression.
    Coleman AL; Miglior S
    Surv Ophthalmol; 2008 Nov; 53 Suppl1():S3-10. PubMed ID: 19038621
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Screening for vascular risk factors in glaucoma: the GVRF study.
    Zeyen T;
    Bull Soc Belge Ophtalmol; 2005; (298):53-60. PubMed ID: 16422222
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prevalence of glaucoma in the wroclaw population. The wroclaw epidemiological study.
    Nizankowska MH; Kaczmarek R
    Ophthalmic Epidemiol; 2005 Dec; 12(6):363-71. PubMed ID: 16283988
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mean intraocular pressure and progression based on corneal thickness in patients with ocular hypertension.
    Konstas AG; Irkec MT; Teus MA; Cvenkel B; Astakhov YS; Sharpe ED; Hollo G; Mylopoulos N; Bozkurt B; Pizzamiglio C; Potyomkin VV; Alemu AM; Nasser QJ; Stewart JA; Stewart WC
    Eye (Lond); 2009 Jan; 23(1):73-8. PubMed ID: 17917683
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Some clinical implications of the collaborative normal tension glaucoma study.
    Drance SM
    Klin Oczna; 2004; 106(4-5):588-92. PubMed ID: 15646475
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effectiveness and safety of dorzolamide-timolol alone or combined with latanoprost in open-angle glaucoma or ocular hypertension.
    Lesk MR; Koulis T; Sampalis F; Sampalis JS; Bastien NR
    Ann Pharmacother; 2008 Apr; 42(4):498-504. PubMed ID: 18364402
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The impact of risk calculation on treatment recommendations made by glaucoma specialists in cases of ocular hypertension.
    Boland MV; Quigley HA; Lehmann HP
    J Glaucoma; 2008 Dec; 17(8):631-8. PubMed ID: 19092458
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A placebo-controlled 3-year study of a calcium blocker on visual field and ocular circulation in glaucoma with low-normal pressure.
    Koseki N; Araie M; Tomidokoro A; Nagahara M; Hasegawa T; Tamaki Y; Yamamoto S
    Ophthalmology; 2008 Nov; 115(11):2049-57. PubMed ID: 18672290
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Evaluation of the role of travoprost 0.004% ophthalmic solution in the management of open angle glaucoma and ocular hypertensive patients.
    Chiselită D;
    Oftalmologia; 2007; 51(2):81-6. PubMed ID: 17937041
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Optic disc and visual field changes after trabeculectomy.
    Kotecha A; Spratt A; Bunce C; Garway-Heath DF; Khaw PT; Viswanathan A;
    Invest Ophthalmol Vis Sci; 2009 Oct; 50(10):4693-9. PubMed ID: 19474409
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A comparison among Humphrey field analyzer, Microperimetry, and Heidelberg Retina Tomograph in the evaluation of macula in primary open angle glaucoma.
    Oztürk F; Yavas GF; Küsbeci T; Ermis SS
    J Glaucoma; 2008 Mar; 17(2):118-21. PubMed ID: 18344757
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of nocturnal blood pressure reduction on circadian fluctuation of mean ocular perfusion pressure: a risk factor for normal tension glaucoma.
    Choi J; Jeong J; Cho HS; Kook MS
    Invest Ophthalmol Vis Sci; 2006 Mar; 47(3):831-6. PubMed ID: 16505014
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Intraocular pressure control following phacoemulsification in patients with chronic angle closure glaucoma.
    Euswas A; Warrasak S
    J Med Assoc Thai; 2005 Nov; 88 Suppl 9():S121-5. PubMed ID: 16681063
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Glaucoma probability score vs Moorfields classification in normal, ocular hypertensive, and glaucomatous eyes.
    Moreno-Montañés J; Antón A; García N; Mendiluce L; Ayala E; Sebastián A
    Am J Ophthalmol; 2008 Feb; 145(2):360-368. PubMed ID: 18045569
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.